DK287883D0 - Fremgangsmade til fremstilling af alicyclisk substituerede oxazolidin-2,4-dion-forbindelser eller farmaceutisk acceptable kationsalte deraf og tilsvarende substituerede alfa-hydroxyacetamider og 2-hydroxyacetonitriler der er nyttige som mellemprodukter - Google Patents

Fremgangsmade til fremstilling af alicyclisk substituerede oxazolidin-2,4-dion-forbindelser eller farmaceutisk acceptable kationsalte deraf og tilsvarende substituerede alfa-hydroxyacetamider og 2-hydroxyacetonitriler der er nyttige som mellemprodukter

Info

Publication number
DK287883D0
DK287883D0 DK2878/83A DK287883A DK287883D0 DK 287883 D0 DK287883 D0 DK 287883D0 DK 2878/83 A DK2878/83 A DK 2878/83A DK 287883 A DK287883 A DK 287883A DK 287883 D0 DK287883 D0 DK 287883D0
Authority
DK
Denmark
Prior art keywords
substituted
preparation
hydroxytyretyd
eyetrodyxetamide
coatal
Prior art date
Application number
DK2878/83A
Other languages
English (en)
Other versions
DK287883A (da
Inventor
Gerald Fagan Holland
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK287883D0 publication Critical patent/DK287883D0/da
Publication of DK287883A publication Critical patent/DK287883A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/42—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/45—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK287883A 1982-06-23 1983-06-22 Fremgangsmaade til fremstilling af alicyclisk substituerede oxazolidin-2,4-dion-forbindelser eller farmaceutisk acceptable kationsalte deraf og tilsvarende substituerede alfa-hydroxyacetamider og 2-hydroxyacetonitriler der er nyttige som mellemprodukter DK287883A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/391,220 US4430337A (en) 1982-06-23 1982-06-23 Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity

Publications (2)

Publication Number Publication Date
DK287883D0 true DK287883D0 (da) 1983-06-22
DK287883A DK287883A (da) 1983-12-24

Family

ID=23545772

Family Applications (1)

Application Number Title Priority Date Filing Date
DK287883A DK287883A (da) 1982-06-23 1983-06-22 Fremgangsmaade til fremstilling af alicyclisk substituerede oxazolidin-2,4-dion-forbindelser eller farmaceutisk acceptable kationsalte deraf og tilsvarende substituerede alfa-hydroxyacetamider og 2-hydroxyacetonitriler der er nyttige som mellemprodukter

Country Status (10)

Country Link
US (1) US4430337A (da)
EP (1) EP0097453B1 (da)
JP (1) JPS5916881A (da)
AT (1) ATE51864T1 (da)
CA (1) CA1197513A (da)
DE (1) DE3381437D1 (da)
DK (1) DK287883A (da)
ES (1) ES523521A0 (da)
GR (1) GR79300B (da)
IE (1) IE55837B1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
TW268952B (da) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
TW403748B (en) 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
CA2376919C (en) 1999-06-18 2008-11-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
DE60032898T2 (de) 1999-06-18 2007-10-25 Merck & Co., Inc. Arylthiazolidindion- und aryloxazolidinderivate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB226529A (en) 1923-12-18 1925-08-13 Arnold I Van Den Bergh S Embal Improvements in and relating to edge trimming and moulding machines for planks and laths
US2338064A (en) 1940-02-10 1943-12-28 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349795A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349796A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349313A (en) 1943-03-01 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2, 4-oxazolidinedione
US2575692A (en) 1947-10-11 1951-11-20 Abbott Lab N-methyl oxazolidine-2, 4-diones
US2575694A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5, 5-trimethyloxazolidine-2, 4-dione
US2575693A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5-dimethyl-5-ethyloxazolidine-2, 4-dione
US2961377A (en) 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3699229A (en) * 1970-12-18 1972-10-17 Abbott Lab 2-oxo-5-phenyl-4-oxazolidinone as an anti-depressant agent
US4200642A (en) 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4367234A (en) 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
GT198170554A (es) * 1980-07-28 1983-01-12 5-oxazolidin-2-4-dionas hipoglicemicas substituidas.
US4332952A (en) 1980-07-28 1982-06-01 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones

Also Published As

Publication number Publication date
IE831461L (en) 1983-12-23
JPS6230993B2 (da) 1987-07-06
DK287883A (da) 1983-12-24
ATE51864T1 (de) 1990-04-15
DE3381437D1 (de) 1990-05-17
CA1197513A (en) 1985-12-03
JPS5916881A (ja) 1984-01-28
EP0097453A3 (en) 1985-06-12
ES8500918A1 (es) 1984-11-01
US4430337A (en) 1984-02-07
ES523521A0 (es) 1984-11-01
IE55837B1 (en) 1991-01-30
GR79300B (da) 1984-10-22
EP0097453A2 (en) 1984-01-04
EP0097453B1 (en) 1990-04-11

Similar Documents

Publication Publication Date Title
DK287883D0 (da) Fremgangsmade til fremstilling af alicyclisk substituerede oxazolidin-2,4-dion-forbindelser eller farmaceutisk acceptable kationsalte deraf og tilsvarende substituerede alfa-hydroxyacetamider og 2-hydroxyacetonitriler der er nyttige som mellemprodukter
DK151882C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 5-substituerede oxazolidin-2,4-dioner eller 3-acylforbindelser eller kationsalte deraf og carboximidat-forbindelser til anvendelse som udgangsmateriale ved fremgangsmaaden
IS1438B6 (is) Forefni til framleiðslu á omeprazole
DE3381465D1 (de) Sebum-auffang und steuermittel.
MX7604E (es) Procedimiento para la infusion de fruta con solutos de azucar
DK159770C (da) Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaaden
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
DK303481A (da) Fremgangsmaade til fremstilling af amider af hydroxyfenyl-alkylaminoaetanoler eller terapeutisk acceptable salte deraf
DK354987D0 (da) Fremgangsmaade til fremstilling af floursulfonamider
DK334781A (da) Fremgangsmaade til fremstilling af racemiske eller optisk aktive 5-substituerede oxazolidin-2,4-dioner eller 3-acylforbindelser deraf eller salte deraf og mellemprodukter ved fremgangsmaaden
DK205883A (da) Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler
DK164379A (da) Fremgangsmaade til fremstilling af 7-methoxy-5-oxo-5h-thiazolo(2,3-b)quinazolin-2-carboxylsyre eller farmaceutisk anvendelige salte deraf
DK532679A (da) Fremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo (4,1,0)hepten-(2)-on-(5).
DK159271C (da) Analogifremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner samt 2-aminobenzamider til brug som udgangsmaterialer ved fremgangsmaaden
IT1121010B (it) Procedimento per la carbonilazione di diolefine
MX173047B (es) Procedimiento para preparar un compuesto de trifluormetilvinilo
JPS525520A (en) Ophthalmo funduscopic camera
SE8202787L (sv) Forfarande for avlegsnande av formylgruppen fran n-formylpeptider och estrar derav
DK231583A (da) Fremgangsmaade til fremstilling af penicillin- og cephalosporinforbindelser samt forbindelser, der er anvendelige som mellemprodukter ved en saadan fremgangsmaade
DK318976A (da) Fremgangsmade til fremstilling af 1,3-dihydro-3-phenyl-1'-(2-propynyl) spiro(isobenzofuran)er
DK74277A (da) Analogifremgangsmade til fremstilling af optisk aktive isomere af oxadiazolderivater eller salte deraf
DK216983D0 (da) Fremgangsmade til fremstilling af 2-substituerede 5-aryl-1,2,3,4-tetrahydro-gamma-carbolin-derivater og forbindelser der er nyttige som mellemprodukter derved
DK286679A (da) Fremgangsmaade til fremstilling af azatetracycliske carbonitriler isaer 2-substituerede 5-cycano-2,3-dihydro-1h-dibenzo (2,3.6,7) thiepino (4,5-c) pyrroler og tilsvarende oxepino-,azepino- og cycloheptatrienoforbindelser og salte deraf
DK13184D0 (da) Analogifremgangsmade til fremstilling af 1-oxo-1h-thiazolo(3,2-a)pyrimidin-2-carboxylsyrer eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolo(3,2-a)pyrimidin-2-carboxylsyreestere til anvendelse som mellemprodukter ved fremgangsmaden
FR2412547A2 (fr) Nouveau derive de la vincamine, sa preparation et son application comme medicament

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment